{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:52:50Z","timestamp":1778507570094,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68458-9","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T04:02:03Z","timestamp":1722052923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching"],"prefix":"10.1038","volume":"14","author":[{"given":"Zixia","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bomin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youben","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"issue":"6","key":"68458_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells, S. A. Jr. et al. Revised american thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6), 567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335 (2015).","journal-title":"Thyroid"},{"issue":"7","key":"68458_CR2","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-21-0368","volume":"29","author":"A Angelousi","year":"2022","unstructured":"Angelousi, A., Hayes, A. R., Chatzellis, E., Kaltsas, G. A. & Grossman, A. B. Metastatic medullary thyroid carcinoma: a new way forward. Endocr. Relat. Cancer 29(7), R85\u2013R103. https:\/\/doi.org\/10.1530\/ERC-21-0368 (2022).","journal-title":"Endocr. Relat. Cancer"},{"key":"68458_CR3","doi-asserted-by":"publisher","first-page":"1119656","DOI":"10.3389\/fendo.2023.1119656","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Mao, Y., You, T. & Chen, G. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system. Front. Endocrinol. (Lausanne) 14, 1119656. https:\/\/doi.org\/10.3389\/fendo.2023.1119656 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"68458_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/thy.2020.0167","volume":"31","author":"A Kotwal","year":"2021","unstructured":"Kotwal, A., Erickson, D., Geske, J. R., Hay, I. D. & Castro, M. R. Predicting outcomes in sporadic and hereditary medullary thyroid carcinoma over two decades. Thyroid 31(4), 616\u2013626. https:\/\/doi.org\/10.1089\/thy.2020.0167 (2021).","journal-title":"Thyroid"},{"issue":"1","key":"68458_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000493977","volume":"8","author":"EM Opsahl","year":"2019","unstructured":"Opsahl, E. M. et al. Trends in diagnostics, surgical treatment, and prognostic factors for outcomes in medullary thyroid carcinoma in Norway: A nationwide population-based study. Eur. Thyroid J. 8(1), 31\u201340. https:\/\/doi.org\/10.1159\/000493977 (2019).","journal-title":"Eur. Thyroid J."},{"issue":"1","key":"68458_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","volume":"161","author":"RW Randle","year":"2017","unstructured":"Randle, R. W. et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161(1), 137\u2013146. https:\/\/doi.org\/10.1016\/j.surg.2016.04.053 (2017).","journal-title":"Surgery"},{"issue":"12","key":"68458_CR7","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti, S. et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Annals Oncol. 30(12), 1856\u20131883. https:\/\/doi.org\/10.1093\/annonc\/mdz400 (2019).","journal-title":"Annals Oncol."},{"issue":"8","key":"68458_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad, R. I. et al. Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 20(8), 925\u2013951. https:\/\/doi.org\/10.6004\/jnccn.2022.0040 (2022).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"68458_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.oraloncology.2018.01.009","volume":"78","author":"X Shi","year":"2018","unstructured":"Shi, X. et al. Prognostic significance and optimal candidates of primary tumor resection in major salivary gland carcinoma patients with distant metastases at initial presentation: A population-based study. Oral Oncol. 78, 87\u201393. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.01.009 (2018).","journal-title":"Oral Oncol."},{"issue":"11","key":"68458_CR10","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1007\/s00432-023-04847-3","volume":"149","author":"W Luo","year":"2023","unstructured":"Luo, W. & Zhang, T. Primary tumor resection enhances the survival of pancreatic neuroendocrine carcinoma patients with liver metastasis under the definition of 2019 WHO classification. J. Cancer Res. Clin. Oncol. 149(11), 9201\u20139212. https:\/\/doi.org\/10.1007\/s00432-023-04847-3 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"13","key":"68458_CR11","doi-asserted-by":"publisher","first-page":"11013","DOI":"10.1007\/s00432-023-04988-5","volume":"149","author":"Y He","year":"2023","unstructured":"He, Y. et al. Primary tumor resection improves survival benefit of stage IVB cervical carcinoma: A new perspective. J. Cancer Res. Clin. Oncol. 149(13), 11013\u201311023. https:\/\/doi.org\/10.1007\/s00432-023-04988-5 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"68458_CR12","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1002\/cam4.2431","volume":"8","author":"M Zheng","year":"2019","unstructured":"Zheng, M., Li, Y., Li, T., Zhang, L. & Zhou, L. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis. Cancer Med. 8(11), 5128\u20135136. https:\/\/doi.org\/10.1002\/cam4.2431 (2019).","journal-title":"Cancer Med."},{"issue":"6","key":"68458_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1097\/sla.0000000000001302","volume":"263","author":"R Warschkow","year":"2016","unstructured":"Warschkow, R. et al. Improved survival after primary tumor surgery in metastatic breast cancer: A propensity-adjusted, population-based SEER trend analysis. Ann. Surg. 263(6), 1188\u20131198. https:\/\/doi.org\/10.1097\/sla.0000000000001302 (2016).","journal-title":"Ann. Surg."},{"issue":"5","key":"68458_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1177\/0194599815627637","volume":"154","author":"TD Patel","year":"2016","unstructured":"Patel, T. D. et al. Utility of surgery radiotherapy in distant metastatic head and neck squamous cell carcinoma: A population-based approach. Otolaryngol. Head Neck Surg. 154(5), 868\u2013874. https:\/\/doi.org\/10.1177\/0194599815627637 (2016).","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"1","key":"68458_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/sla.0000000000000860","volume":"262","author":"I Tarantino","year":"2015","unstructured":"Tarantino, I. et al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: A population-based, propensity score-adjusted trend analysis. Ann. Surg. 262(1), 112\u2013120. https:\/\/doi.org\/10.1097\/sla.0000000000000860 (2015).","journal-title":"Ann. Surg."},{"issue":"2","key":"68458_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2020.09.025","volume":"221","author":"ZT Sahli","year":"2021","unstructured":"Sahli, Z. T., Canner, J. K., Zeiger, M. A. & Mathur, A. Association between age and disease specific mortality in medullary thyroid cancer. Am. J. Surg. 221(2), 478\u2013484. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.09.025 (2021).","journal-title":"Am. J. Surg."},{"issue":"8 Pt 2","key":"68458_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-127-8_part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin, D. B. Estimating causal effects from large data sets using propensity scores. Ann. Internal Med. 127(8 Pt 2), 757\u2013763. https:\/\/doi.org\/10.7326\/0003-4819-127-8_part_2-199710151-00064 (1997).","journal-title":"Ann. Internal Med."},{"key":"68458_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew, G. et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int. J. Surg. 96, 106165. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106165 (2021).","journal-title":"Int. J. Surg."},{"issue":"1","key":"68458_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/thy.2022.0353","volume":"33","author":"A Wilhelm","year":"2023","unstructured":"Wilhelm, A. et al. Disease-specific survival trends for patients presenting with Differentiated thyroid cancer and distant metastases in the United States, 1992\u20132018. Thyroid 33(1), 63\u201373. https:\/\/doi.org\/10.1089\/thy.2022.0353 (2023).","journal-title":"Thyroid"},{"issue":"1","key":"68458_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"issue":"10","key":"68458_CR21","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hed.23619","volume":"36","author":"ML Shindo","year":"2014","unstructured":"Shindo, M. L. et al. Management of invasive well-differentiated thyroid cancer: An American Head and Neck Society consensus statement AHNS Consensus Statement. Head Neck 36(10), 1379\u20131390. https:\/\/doi.org\/10.1002\/hed.23619 (2014).","journal-title":"Head Neck"},{"issue":"10","key":"68458_CR22","doi-asserted-by":"publisher","first-page":"e3911","DOI":"10.1210\/clinem\/dgab436","volume":"106","author":"J Simoes-Pereira","year":"2021","unstructured":"Simoes-Pereira, J. et al. Avidity and outcomes of radioiodine therapy for distant metastasis of distinct types of differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 106(10), e3911\u2013e3922. https:\/\/doi.org\/10.1210\/clinem\/dgab436 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68458_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae214","author":"CQ Liu","year":"2024","unstructured":"Liu, C. Q. et al. Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae214 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"68458_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/hed.26987","volume":"44","author":"HG Vuong","year":"2022","unstructured":"Vuong, H. G., Le, M. K., Hassell, L., Kondo, T. & Kakudo, K. The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes. Head Neck 44(4), 926\u2013932. https:\/\/doi.org\/10.1002\/hed.26987 (2022).","journal-title":"Head Neck"},{"issue":"3","key":"68458_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100183","volume":"6","author":"B Kiesewetter","year":"2021","unstructured":"Kiesewetter, B., Riss, P., Scheuba, C. & Raderer, M. How I treat medullary thyroid cancer. ESMO Open 6(3), 100183. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100183 (2021).","journal-title":"ESMO Open"},{"issue":"2","key":"68458_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","volume":"30","author":"SA Wells Jr","year":"2012","unstructured":"Wells, S. A. Jr. et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J. Clin. Oncol. 30(2), 134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2011.35.5040 (2012).","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"68458_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa2005651","volume":"383","author":"LJ Wirth","year":"2020","unstructured":"Wirth, L. J. et al. Efficacy of selpercatinib in RET-altered thyroid cancers. N Engl. J. Med. 383(9), 825\u2013835. https:\/\/doi.org\/10.1056\/NEJMoa2005651 (2020).","journal-title":"N Engl. J. Med."},{"issue":"8","key":"68458_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S2213-8587(21)00120-0","volume":"9","author":"V Subbiah","year":"2021","unstructured":"Subbiah, V. et al. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): A multi-cohort, open-label, registrational, phase 1\/2 study. Lancet Diabetes Endocrinol. 9(8), 491\u2013501. https:\/\/doi.org\/10.1016\/S2213-8587(21)00120-0 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"13","key":"68458_CR29","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1158\/1078-0432.CCR-20-2950","volume":"27","author":"D Li","year":"2021","unstructured":"Li, D. et al. Anlotinib in locally advanced or metastatic medullary thyroid carcinoma: A randomized, double-blind phase IIB trial. Clin. Cancer Res. 27(13), 3567\u20133575. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2950 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"68458_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1089\/thy.2022.0504","volume":"33","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Surgery after BRAF-directed therapy is associated with improved survival in BRAF(V600E) mutant anaplastic thyroid cancer: A single-center retrospective cohort study. Thyroid 33(4), 484\u2013491. https:\/\/doi.org\/10.1089\/thy.2022.0504 (2023).","journal-title":"Thyroid"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68458-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T04:02:52Z","timestamp":1722052972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68458-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68458"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68458-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,27]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17260"}}